ROTH MKM initiated coverage on Longeveron with a new price target
$LGVN
Biotechnology: Pharmaceutical Preparations
Health Care
ROTH MKM initiated coverage of Longeveron with a rating of Buy and set a new price target of $10.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/6/2024 | $10.00 | Buy | ROTH MKM |
| 1/5/2022 | $20.00 | Buy | EF Hutton |